(Q112987302)

English

ALOX5 binds ALOX5 inhibitors

An instance of the biological reaction in Homo sapiens with Reactome ID (R-HSA-9707186)

In more languages

edit

Statements

1 reference

8 July 2022

Synthesis of Leukotrienes (LT) and Eoxins (EX)

1 reference

8 July 2022

1 reference

8 July 2022

https://identifiers.org/reactome:R-HSA-9707186

1 reference

8 July 2022

ALOX5 inhibitors [cytosol]

1

1 reference

8 July 2022

ALOX5:ALOX5AP:LTC4S [nuclear envelope]

1

1 reference

8 July 2022

ALOX5:ALOX5 inhibitors [nuclear envelope]

1

1 reference

8 July 2022

Recent advances in the search for novel 5-lipoxygenase inhibitors for the treatment of asthma.

1 reference

8 July 2022

Role of prostaglandins in ulcerative colitis. Enhanced production during active disease and inhibition by sulfasalazine

1 reference

8 July 2022

Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study

1 reference

8 July 2022

Olsalazine in active ulcerative colitis

1 reference

8 July 2022

Modulation of human colonic arachidonic acid metabolism by sulfasalazine.

1 reference

8 July 2022

Pharmacological and biochemical actions of sulphasalazine

1 reference

8 July 2022

Balsalazide: a novel 5-aminosalicylate prodrug for the treatment of active ulcerative colitis

1 reference

8 July 2022

Inhibition of 5-lipoxygenase pathway of arachidonic acid metabolism in human neutrophils by sulfasalazine and 5-aminosalicylic acid.

1 reference

8 July 2022

Meclofenamate sodium is an inhibitor of both the 5-lipoxygenase and cyclooxygenase pathways of the arachidonic acid cascade in vitro

1 reference

8 July 2022

Zileuton, a new efficient and safe systemic anti-acne drug

1 reference

8 July 2022

Maximum Time of the Effect of Antileukotriene - Zileuton in Treatment of Patients with Bronchial Asthma

1 reference

8 July 2022

5-lipoxygenase inhibitory activity of zileuton

1 reference

8 July 2022

5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease

1 reference

8 July 2022

Zileuton, an oral 5-lipoxygenase inhibitor, directly reduces sebum production

1 reference

8 July 2022

Clinical pharmacokinetics of sulphasalazine, its metabolites and other prodrugs of 5-aminosalicylic acid

1 reference

8 July 2022

Oral 5-aminosalicylic acid for induction of remission in ulcerative colitis

1 reference

8 July 2022

Identifiers

1 reference

8 July 2022

(Q112987302)

ALOX5 binds ALOX5 inhibitors

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)